- 专利标题: Crystalline form of a quinolinone-carboxamide compound
-
申请号: US14816237申请日: 2015-08-03
-
公开(公告)号: US09402840B2公开(公告)日: 2016-08-02
- 发明人: Paul R. Fatheree , S. Derek Turner , Adam A. Goldblum , Robert S. Chao , Daniel Genov
- 申请人: Paul R. Fatheree , S. Derek Turner , Adam A. Goldblum , Robert S. Chao , Daniel Genov
- 申请人地址: US CA South San Francisco
- 专利权人: Theravance Biopharma R&D IP, LLC
- 当前专利权人: Theravance Biopharma R&D IP, LLC
- 当前专利权人地址: US CA South San Francisco
- 代理商 Jeffrey A. Hagenah; Roberta P. Saxon
- 主分类号: A61K31/46
- IPC分类号: A61K31/46 ; C07D451/02
摘要:
The invention provides a crystalline hydrochloride salt of 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[(R)-2-hydroxy-3-(methanesulfonyl-methyl-amino)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide or a solvate thereof. The invention also provides pharmaceutical compositions comprising such crystalline salt forms, methods of using such crystalline salt forms to treat diseases associated with 5-HT4 receptor activity, and processes useful for preparing such crystalline salt forms.
公开/授权文献
- US20160095849A1 CRYSTALLINE FORM OF A QUINOLINONE-CARBOXAMIDE COMPOUND 公开/授权日:2016-04-07